COVID-19 and end stage renal disease treatment modalities in the United States
<p>From the establishment of nearly universal health coverage for end stage renal disease in 1972 to 2021, the primary treatment modality has been in-center hemodialysis despite significant advances in home therapies such as peritoneal dialysis and home hemodialysis. </p>
Saved in:
Main Author: | John D Sullivan (Author) |
---|---|
Format: | Book |
Published: |
Archives of Renal Diseases and Management - Peertechz Publications,
2021-09-28.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How end stage renal disease creates, enhances and promotes poverty for patients in the United States
by: John D Sullivan
Published: (2019) -
Extent of malnutrition in end-stage renal disease patients
by: Nazar Chaudhary Muhammad Junaid, et al.
Published: (2014) -
End-stage kidney disease and COVID-19: An incentive to consider other renal replacement therapies
by: Sima Sadat Hejazi, et al.
Published: (2021) -
Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis.
by: Tanawin Nopsopon, et al.
Published: (2021) -
Quality of Life in Patients with End Stage Renal Disease
by: M Rambod, et al.
Published: (2008)